Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
COL10A1 encodes the alpha-1 chain of type X collagen, a homotrimeric extracellular matrix protein expressed by hypertrophic chondrocytes in the growth plate. Heterozygous mutations in COL10A1 cause Schmid metaphyseal chondrodysplasia (SMCD), an autosomal dominant skeletal dysplasia characterized by short stature, coxa vara, genu varum, and waddling gait. The evidence base includes multiple unrelated families and functional assays delineating the pathogenic mechanism. This summary evaluates the clinical validity using ClinGen criteria and integrates genetic and experimental data to guide diagnosis and management.
The association of COL10A1 with SMCD is Definitive. Over 30 probands from at least 15 unrelated autosomal dominant families have been reported, each carrying heterozygous COL10A1 variants that segregate with disease ([PMID:8004099]; [PMID:15880705]). Functional concordance across decades of studies confirms a consistent molecular mechanism, and no significant conflicting evidence has been reported.
SMCD is inherited in an autosomal dominant manner. Segregation analyses have documented at least 15 affected relatives with co-segregating COL10A1 variants ([PMID:8004099]). To date, more than 33 distinct pathogenic variants have been identified, including missense substitutions, frameshift insertions/deletions, and nonsense mutations predominantly clustering in the C-terminal NC1 trimerization domain. For example, c.1853G>T (p.Gly618Val) impairs NC1-mediated assembly ([PMID:7876225]). Recurrent mutations such as 1992delCT have arisen independently in multiple lineages, indicating a mutational hotspot ([PMID:8996971]).
Most SMCD variants lie in exon 3 encoding the NC1 domain, disrupting trimer formation by altering key glycine, tyrosine, or proline residues. Variant types include 18 missense (e.g., c.1853G>T (p.Gly618Val)), 10 frameshifts (e.g., c.1992_1993delCT (p.Leu665Ter)), and 5 nonsense mutations (e.g., c.1896C>A (p.Tyr632Ter)). Phenotypically, heterozygotes uniformly exhibit metaphyseal dysplasia, short stature (HP:0004322), coxa vara (HP:0002812), genu varum (HP:0002970), and waddling gait (HP:0002515).
In vitro expression and trimer assembly assays demonstrate that NC1 missense and truncating mutations prevent collagen X multimer formation without dominant interference of the wild‐type chains ([PMID:8662807]). Cartilage analyses confirm nonsense-mediated mRNA decay and haploinsufficiency for PTC alleles ([PMID:9525992]). Mouse models harboring Col10a1 NC1 mutations recapitulate the expanded hypertrophic zone, ER stress, and unfolded protein response observed in patient cartilage, indicating both haploinsufficiency and potential dominant-negative effects ([PMID:17403716]).
The definitive gene–disease relationship and clear molecular mechanism support the use of COL10A1 sequencing for diagnosis and family screening of SMCD. Knowledge of hotspot regions facilitates targeted testing, and functional understanding opens avenues for therapeutic modulation of ER stress. Key take-home: COL10A1 NC1 domain mutations cause SMCD via impaired trimer assembly and haploinsufficiency, justifying genetic testing for early diagnosis and management.
Gene–Disease AssociationDefinitiveOver 30 probands from at least 15 unrelated autosomal dominant families with consistent functional evidence Genetic EvidenceStrong30 probands in 15 unrelated families; autosomal dominant segregation and clustering of 33 NC1-domain variants ([PMID:8004099]; [PMID:15880705]) Functional EvidenceStrongIn vitro and in vivo studies show NC1 mutations impair trimer assembly, trigger ER stress, and cause haploinsufficiency/dominant-negative effects ([PMID:8662807]; [PMID:9525992]; [PMID:17403716]) |